Delivery Order SPE2D020D0005-SPE2D325F378Q
Award Date 9/3/25
Potential Completion Date 9/8/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Congers, NY 10920, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Department's Medical Supply Chain awarded a $1,776.75 firm fixed-price delivery order to Chartwell RX LLC on August 20, 2025, for the supply of Ondansetron Orally Disintegrating Tablets (ODT) 4 mg in a quantity of 30 tablets. The contract, issued without a set-aside designation, is scheduled for completion by August 25, 2025, with performance taking place at Chartwell RX's facility in Congers, New York. Ondansetron is an antiemetic medication commonly used to prevent nausea...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,184.50 to Chartwell RX LLC for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. The award was issued on July 30, 2025, with an ultimate completion date of August 4, 2025, under a firm fixed-price contract type with no set-aside designation. Chartwell RX LLC, a pharmaceutical company headquartered in Congers, New York, will fulfill this order from its place of performance at the same...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order to Chartwell RX LLC for the supply of Ondansetron ODT (Orally Disintegrating Tablets) 4 mg in quantities of 30 tablets. This firm fixed-price delivery order, valued at $1,302.95, was issued on September 3, 2025, with an ultimate completion date of September 8, 2025. The contract carries no set-aside designation and will be performed at Chartwell RX's facility in Congers, New York. Ondansetron is a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to Chartwell RX LLC on September 2, 2025, for the supply of Ondansetron ODT (orally disintegrating tablets) 4 mg in quantities of 30 tablets. This is a firm fixed-price delivery order with a ceiling value of $3,553.50 and an ultimate completion date of September 5, 2025. The contract was awarded without a set-aside designation and will be performed at Chartwell RX's facility in Congers, New York. Ondansetron is...
- The U.S. Department of Defense Medical Supply Chain has awarded a delivery order valued at $1,578.48 to Chartwell RX LLC for the supply of Ondansetron ODT (orally disintegrating tablets) 8 mg in a quantity of 30 tablets. The contract was awarded on August 11, 2025, with an ultimate completion date of August 14, 2025, and carries a firm fixed price with no small business set-aside designation. Performance will be executed at Chartwell RX's facility located in Congers, New York. Chartwell RX...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Chartwell RX LLC on August 4, 2025, for the supply of Ondansetron orally disintegrating tablets in 4 milligram strength, with a ceiling value of $1,066.05 and an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a continuation of the government's pharmaceutical supply chain through an Indefinite Delivery Vehicle contract...
- This delivery order, awarded on September 3, 2025, by the Medical Supply Chain to Chartwell RX LLC, provides 30 tablets of Ondansetron Orally Disintegrating Tablets (ODT) 4 mg under a firm fixed-price contract with a ceiling value of $1,421.40. The contract, which is not designated as a set-aside, is to be performed in Congers, New York, with an ultimate completion date of September 8, 2025. Ondansetron is an antiemetic medication commonly used to prevent nausea and vomiting in medical settings,...
- This is a delivery order awarded to Chartwell RX LLC, a pharmaceutical company based in Congers, New York, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,724.35 firm-fixed-price contract is for the delivery of ondansetron orally disintegrating tablets (ODT) 4 mg, with a completion date of July 25, 2024. Chartwell RX LLC is a for-profit organization registered in the System for Award Management (SAM) that specializes in providing a wide range of branded and generic...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Chartwell RX LLC for $236 to supply 30 ondansetron ODT 4 mg tablets by September 21, 2023. The delivery order was issued against an existing contract vehicle on September 18, 2023 with no set-aside designation. Chartwell RX LLC will fulfill the order from its location in Congers, New York to supply the antiemetic medication ondansetron to the Defense Logistics Agency in support of its medical...
- The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order to Chartwell RX LLC, a for-profit organization, to provide 30-count packages of the pharmaceutical product Ondansetron ODT 8 mg Tablet. The contract has a Potential Value of $4,932.75 and a Completion Date of January 10, 2024. The order was issued without the use of any set-aside designations. Chartwell RX LLC is an existing vendor for the Defense Logistics Agency Troop Support Medical, having previously...